Research News
GW researchers found low dose aspirin may reduce the need for mechanical ventilation, ICU admission and in-hospital mortality in hospitalized COVID-19 patients. Final results indicating the lung protective effects of aspirin were published today...
The GW Department of Dermatology received a $250,000 grant from Pfizer to expand accessible teledermatology for atopic dermatitis patients in Washington, D.C.
The George Washington University announced today its participation in a Sanofi COVID-19 vaccine clinical trial. GW was selected as one of approximately 25 sites in the United States to launch a phase 2 study for its adjuvanted recombinant protein...
Researchers at the George Washington University found that the majority of dermatology patients were comfortable with virtual visits as an alternative to in-person appointments.
Images that highlight the beauty and breadth of biomedical research and a passion for science at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) were on display in the annual SMHS Art of Science contest.
A group of interdisciplinary researchers received more than $3.3 million in grants for their research on networks within the autonomic nervous system and therapies that may lead to new treatments for heart attack and sleep apnea.
A recent study by GW physicians on the severity of acute respiratory viral adverse events related to antirheumatic disease therapies found that some therapies may be associated with increased respiratory viral events while others don’t show...
While COVID-19 infected patients should be treated with standard anticoagulation therapies, such as blood thinning medication, a new study by researchers at the George Washington University shows that anticoagulating patients at higher doses,...
Third-year MD student King John Pascual and mentor Ali Pourmand, MD, from SMHS are presenting findings at the American College of Emergency Physicians on the role of Google searches during the early phase of the pandemic in the U.S.
Moncef Slaoui, PhD, MBA, chief adviser for the COVID-19 vaccine development initiative Operation Warp Speed, visited GW on Oct. 21 to raise awareness for the national vaccine development efforts, encourage greater participation in the clinical...
